SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001636282-24-000109
Filing Date
2024-11-18
Accepted
2024-11-18 16:05:24
Documents
68
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q/A syre-20240331.htm   iXBRL 10-Q/A 891495
2 EX-31.1 spyre-20240331xex311a.htm EX-31.1 9607
3 EX-31.2 spyre-20240331xex312a.htm EX-31.2 9616
4 EX-32.1 spyre-20240331xex321a.htm EX-32.1 6321
  Complete submission text file 0001636282-24-000109.txt   6105451

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT syre-20240331.xsd EX-101.SCH 46812
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT syre-20240331_cal.xml EX-101.CAL 55669
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT syre-20240331_def.xml EX-101.DEF 324740
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT syre-20240331_lab.xml EX-101.LAB 531618
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT syre-20240331_pre.xml EX-101.PRE 418456
71 EXTRACTED XBRL INSTANCE DOCUMENT syre-20240331_htm.xml XML 862168
Mailing Address 221 CRESCENT STREET BUILDING 23, SUITE 105 WALTHAM MA 02453
Business Address 221 CRESCENT STREET BUILDING 23, SUITE 105 WALTHAM MA 02453 6176515940
Spyre Therapeutics, Inc. (Filer) CIK: 0001636282 (see all company filings)

IRS No.: 464312787 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 001-37722 | Film No.: 241471478
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)